Search Results - "Larsen, Wilma"

Refine Results
  1. 1
  2. 2

    Randomized trial of cesarean vs vaginal delivery for effects on the pelvic floor in squirrel monkeys by Lindo, Fiona M., MD, MPH, Carr, Emily S., BS, Reyes, Michelle, BA, Gendron, Jilene M., RT (R), Ruiz, Julio C., DVM, Parks, Virginia L., BS, Kuehl, Thomas J., PhD, Larsen, Wilma I., MD

    “…Background Vaginal delivery is a risk factor in pelvic floor disorders. We previously described changes in the pelvic floor associated with pregnancy and…”
    Get full text
    Journal Article
  3. 3

    Variation in Use of Prophylactic Antibiotics in Gynecologic Procedures Before and After an Educational Intervention by Wu, Emily, Langsjoen, Jessica, Pruszynski, Jessica, Kuehl, Thomas J, Larsen, Wilma I

    “…Guidelines for use of prophylactic antibiotics in gynecologic procedures are outlined by the American Congress of Obstetricians and Gynecologists. There…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    The Certification Process Driving Patient Safety by Shivraj, Pooja, MS, PhD, Novak, Amanda, MEd, Aziz, Sylvia, MHA, Larsen, Wilma, MD, Ramin, Susan, MD

    “…In 2016, the American Board of Medical Specialties (ABMS) and the National Patient Safety Foundation issued a joint call encouraging each ABMS member board to…”
    Get full text
    Journal Article
  7. 7

    Risk Factors for Late Postpartum Preeclampsia by LARSEN, Wilma I, STRONG, Jennifer E, FARLEY, John H

    Published in Journal of reproductive medicine (01-01-2012)
    “…To determine the risk factors for late postpartum preeclampsia. This was a retrospective case control study of women readmitted in the postpartum period (>48…”
    Get full text
    Journal Article
  8. 8

    Inappropriate Use of Antibiotics in Patients Undergoing Gynecologic Surgery by Joyce, John, Langsjoen, Jessica, Sharadin, Cynthia, Kuehl, Thomas J., Larsen, Wilma I.

    “…We retrospectively examined prophylactic antibiotic use and documentation of wound classification in patients having gynecologic surgery at a tertiary…”
    Get full text
    Journal Article
  9. 9

    Recognition and Management of Nerve Entrapment Pain After Uterosacral Ligament Suspension by Chung, Christopher P., Kuehl, Thomas J., Larsen, Wilma I., Yandell, Paul M., Shull, Bob L.

    Published in Obstetrics and gynecology (New York. 1953) (01-08-2012)
    “…To estimate the incidence, risk factors, and characteristics of neuropathic pain related to nerve entrapment after uterosacral ligament suspension. A review of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Incidence of Bladder Injury During Retropubic Midurethral Sling Placement After Prior Burch Colpopexy by Gephart, Laura Faye, Kuehl, Thomas J, Reyes, Michelle, Yandell, Paul M, Larsen, Wilma I

    “…OBJECTIVESTo elucidate if prior Burch changes the risk of bladder injury or rates of voiding dysfunction and continence in the immediate postoperative period…”
    Get full text
    Journal Article
  12. 12

    Perineal Body Length and Perineal Lacerations During Delivery in Primigravid Patients by Lane, T. Lance, Chung, Christopher P., Yandell, Paul M., Kuehl, Thomas J., Larsen, Wilma I.

    “…This study assessed the relation between perineal body length and the risk of perineal laceration extending into the anal sphincter during vaginal delivery in…”
    Get full text
    Journal Article
  13. 13

    Incidence and risk factors of postoperative urinary tract infection after uterosacral ligament suspension by Chung, Christopher P., Kuehl, Thomas J., Harris, Sheena K., McBride, Madeline M., Larsen, Wilma I., Yandell, Paul M., Shull, Bobby L.

    Published in International Urogynecology Journal (01-07-2012)
    “…Introduction and hypothesis We assessed the incidence of and risk factors for developing urinary tract infection (UTI) after uterosacral ligament suspension…”
    Get full text
    Journal Article
  14. 14

    A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia by Farley, John H, Truong, Vu, Goo, Elwin, Uyehara, Catherine, Belnap, Christina, Larsen, Wilma I

    Published in Gynecologic oncology (01-11-2006)
    “…The objective of the study was to evaluate the efficacy of daily Celecoxib in the regression of moderate and severe cervical dysplasia, when compared to…”
    Get full text
    Journal Article
  15. 15

    Lack of preoperative predictors of the immediate return of postoperative bladder emptying after uterosacral ligament suspension by Chung, Christopher P, Kuehl, Thomas J, Spoonts, Kimberly M, Martins, Danilo A, Larsen, Wilma I, Yandell, Paul M, Shull, Bobby L

    “…To determine whether preoperative postvoid residual volume (PVR), pelvic organ prolapse quantification (POPQ) stage, patient characteristics, or concurrent…”
    Get full text
    Journal Article
  16. 16

    Pelvic organ prolapse and urinary incontinence in nulliparous women at the United States Military Academy by Larsen, Wilma I, Yavorek, Trudy A

    Published in International Urogynecology Journal (01-05-2006)
    “…The objective of this study was to evaluate both baseline pelvic support and incontinence in relation to physical activity in nulliparous college women…”
    Get full text
    Journal Article
  17. 17

    Grading of squamous dysplasia in endocervical curettage specimens : The case for conservative management of mild endocervical dysplasia by PETERSEN, Maj Scott, BELNAP, Christina, LARSEN, Wilma I, FARLEY, John

    Published in Journal of reproductive medicine (01-10-2007)
    “…To determine if the severity of dysplasia in a loop electrical excision procedure (LEEP) specimen is different for women with a preoperative endocervical…”
    Get full text
    Journal Article
  18. 18

    Patterns of Care for Cervical Cancer Patients Treated in the U.S. Military Health Care System by FARLEY, John H, HARLAN, Linda C, CLEGG, Limin X, LARSEN, Wilma I, TRIMBLE, Edward L

    Published in Journal of reproductive medicine (01-11-2007)
    “…To determine whether women diagnosed with cervical cancer within the U.S. Department of Defense (DOD) Military Health Care System received treatment within…”
    Get full text
    Journal Article
  19. 19
  20. 20